X Trademark

Trademark Overview

On Thursday, July 1, 2010, a trademark application was filed for X with the United States Patent and Trademark Office. The USPTO has given the X trademark a serial number of 85075969. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, October 5, 2023. This trademark is owned by Meda Pharmaceuticals Inc.. The X trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-inflammatory and antiviral preparations for topical treatment of cold sores
x

General Information

Serial Number85075969
Word MarkX
Filing DateThursday, July 1, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, October 5, 2023
Registration Number4505585
Registration DateTuesday, April 1, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 7, 2010

Trademark Statements

Description of MarkThe mark consists of two intersecting curved lines forming a stylized letter "X" where the stylized letter "X" is surrounded by a curved band in the form of an incomplete circle.
Goods and ServicesPharmaceutical preparations, namely, anti-inflammatory and antiviral preparations for topical treatment of cold sores
Pseudo MarkX
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 6, 2010
Primary Code005
First Use Anywhere DateTuesday, February 1, 2011
First Use In Commerce DateTuesday, February 1, 2011

Trademark Owner History

Party NameMEDA PHARMACEUTICALS INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMEDA PHARMA S.À.R.L.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressN/A L-1855
LU
Party NameMeda Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameMeda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameMeda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events

Event DateEvent Description
Thursday, October 5, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, October 5, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, October 5, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 4, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 3, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, April 1, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, July 24, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, July 24, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, July 24, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 7, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 5, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 5, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 10, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 16, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 1, 2014REGISTERED-PRINCIPAL REGISTER
Saturday, February 22, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Friday, February 21, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, February 21, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 20, 2014STATEMENT OF USE PROCESSING COMPLETE
Sunday, January 12, 2014USE AMENDMENT FILED
Wednesday, January 29, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, September 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, September 4, 2013SOU EXTENSION 5 GRANTED
Thursday, August 1, 2013SOU EXTENSION 5 FILED
Friday, August 30, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 1, 2013SOU TEAS EXTENSION RECEIVED
Friday, November 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, November 1, 2012SOU EXTENSION 4 GRANTED
Monday, October 29, 2012SOU EXTENSION 4 FILED
Monday, October 29, 2012SOU TEAS EXTENSION RECEIVED
Thursday, August 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, August 8, 2012SOU EXTENSION 3 GRANTED
Wednesday, August 1, 2012SOU EXTENSION 3 FILED
Wednesday, August 1, 2012SOU TEAS EXTENSION RECEIVED
Thursday, March 1, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, February 29, 2012SOU EXTENSION 2 GRANTED
Wednesday, February 1, 2012SOU EXTENSION 2 FILED
Wednesday, February 29, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 1, 2012SOU TEAS EXTENSION RECEIVED
Saturday, July 30, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, July 28, 2011SOU EXTENSION 1 GRANTED
Thursday, July 28, 2011SOU EXTENSION 1 FILED
Thursday, July 28, 2011SOU TEAS EXTENSION RECEIVED
Tuesday, February 1, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 2010PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2010NOTICE OF PUBLICATION
Tuesday, November 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 2, 2010ASSIGNED TO LIE
Tuesday, October 19, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 12, 2010ASSIGNED TO EXAMINER
Wednesday, July 7, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, July 6, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 5, 2010NEW APPLICATION ENTERED

Related Keywords

preparations treatment cold sores topical inflammatory namely anti pharmaceutical antiviral